Skip to main content
. 2018 Jan 25;5(2):156–159. doi: 10.1002/mdc3.12572

Table 1.

Characteristics of Patients and Healthy Participants

Characteristic Mean ± SD (range)
PD patients, n = 80 Healthy participants, n = 60
Age, y 68.5 ± 7.5 (49–81) 66.9 ± 9.9 (52–83)
Sex: no. of men/women 40/40 30/30
Handedness: no. right/left 78/2 56/4
MoCA score 26.4 ± 2.1 (21–30)
Disease duration, y 5.8 ± 3.3 (0–14)
Hoehn & Yahr stage on 2.0 ± 0.7 (1–4)
Levodopa equivalent, mg/d 624.3 ± 392 (60–1855)
PDQ‐39 score 39.93 ± 22.2 (5.0–91.0)
CR task: Mean score 8.6 ± 3.0 (2.5–15.5) 14.2 ± 3.0 (6.5–22.5)
Right 8.9 ± 3.4 (1.0–17.5) 14.9 ± 3.1 (6.5–22.5)
Left 8.2 ± 3.6 (2.5–16.0) 13.8 ± 3.2 (5.4–22.0)
DextQ‐24 score 38.5 ± 10.1 (24–73)
MDS‐UPDRS scoresa
Part I 10.1 ± 5.2 (1–23)
Part II 4.9 ± 2.6 (0–11)
Part III 14.5 ± 5.5 (4–29)
a

MDS‐UPDRS part II contains Items 2.4 through 2.7, and part III contains Items 3.3 through 3.6 and Items 3.15 through 3.18.

Abbreviations: SD, standard deviation: PD, Parkinson's disease; MoCA, Montreal Cognitive Assessment; on, on medication; PDQ, Parkinson's Disease Questionnaire 39; CR, coin rotation; DextQ‐24, Dexterity questionnaire 24; MDS‐UPDRS, Movement Disorder Society‐Unified Parkinson's Disease Rating Scale.